CSL (CSLLY) Stock Forecast & Price Target

$19.00 0.00 (0.00%)

As of 06/18/2026 03:59 PM Eastern

Compare

CSL - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Reduce

Based on 5 Analyst Ratings

Sell
1

Hold
4

Buy
0

Based on 5 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 5 analysts, 1 has given a sell rating, and 4 have given a hold rating for CSLLY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CSLLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSLLY Analyst Ratings Over Time

Type	Current Forecast 6/19/25 to 6/19/26	1 Month Ago 5/20/25 to 5/20/26	3 Months Ago 3/21/25 to 3/21/26	1 Year Ago 6/19/24 to 6/19/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	2 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Reduce	Reduce	Moderate Buy	Strong Buy

CSLLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CSLLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CSL Stock vs. The Competition

Type	CSL	Medical Companies	Broader Market
Consensus Rating Score	1.80	2.29	2.52
Consensus Rating	Reduce	Hold	Moderate Buy
Predicted Upside	N/A	686.68% Upside	15.89% Upside
News Sentiment Rating	Neutral News See Recent CSLLY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating
5/29/2026	Jefferies Financial Group 2 of 5 stars		Downgrade	Strong-Buy ➝ Hold
5/11/2026	Canaccord Genuity Group 4 of 5 stars		Downgrade	Strong-Buy ➝ Hold
5/11/2026	Zacks Research Not Rated		Downgrade	Hold ➝ Strong Sell
5/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
2/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Moderate Buy ➝ Hold
1/16/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	D. Thillainathan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/13/2024	Macquarie Infrastructure Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	D. Bailey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 11:23 AM ET.

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, June 16, 2026. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSL
Bull Case

Here are some ways that investors could benefit from investing in CSL Limited:

The current stock price is around $69.33, which may present a buying opportunity for investors looking to enter at a favorable valuation.
CSL Limited operates in the biopharmaceutical sector, which has shown resilience and growth potential, particularly in areas like gene therapies and plasma products.
The company has a diversified product portfolio across multiple segments, including CSL Behring, CSL Seqirus, and CSL Vifor, reducing reliance on any single revenue stream.
CSL Limited has a strong international presence, with operations in key markets such as the United States, Germany, and China, which can help mitigate regional economic fluctuations.
Recent advancements in their product offerings, particularly in gene therapies and innovative vaccines, position CSL Limited well for future growth in the healthcare market.

CSL
Bear Case

Investors should be bearish about investing in CSL Limited for these reasons:

There has been a slight decrease in short interest, indicating some investor skepticism about the stock's performance in the near term.
CSL Limited's stock has shown limited movement in the past year, with a performance increase of only about 0.25%, suggesting potential stagnation.
The company has a relatively low institutional ownership percentage, which may indicate a lack of confidence from larger investors.
With a high average daily volume, any negative news could lead to significant price volatility, which may deter risk-averse investors.
CSL Limited operates in a highly competitive industry, where rapid advancements and regulatory changes can impact market position and profitability.

CSLLY Forecast - Frequently Asked Questions

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last twelve months. There is currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CSLLY shares.

According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, CSL's stock had 4 downgrades by analysts.

CSL has been rated by research analysts at Canaccord Genuity Group, Citigroup, Jefferies Financial Group, and Zacks Research in the past 90 days.

Analysts like CSL less than other "medical" companies. The consensus rating for CSL is Reduce while the average consensus rating for "medical" companies is Hold. Learn more on how CSLLY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With CSL Recommendations

This page (OTCMKTS:CSLLY) was last updated on 6/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CSL (CSLLY) Stock Forecast & Price Target

CSL - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CSLLY Analyst Ratings Over Time

CSLLY Analyst Recommendations By Month

CSLLY Price Targets by Month

CSL Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

CSL
Bull Case

CSL
Bear Case

CSLLY Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With CSL Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CSL (CSLLY) Stock Forecast & Price Target

CSL - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CSLLY Analyst Ratings Over Time

CSLLY Analyst Recommendations By Month

CSLLY Price Targets by Month

CSL Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

CSL Bull Case

CSL Bear Case

CSLLY Forecast - Frequently Asked Questions

Should I buy or sell CSL stock right now?

Does CSL's stock price have much downside?

Has CSL been downgraded by Wall Street analysts recently?

What analysts cover CSL?

Do Wall Street analysts like CSL more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With CSL Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

CSL
Bull Case

CSL
Bear Case